Form 4 for WGS GeneDx Holdings Corp.
Accepted 2022-01-27 00:00:00 ET · period of report 2022-01-25 · accession 0001209191-22-005286 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-27 | 2022-01-25 | WGS | Schadt Eric | CEO, Dir | M - OptEx | — | +78.8K | 129.6K | +155% | — |
| D | 2022-01-27 | 2022-01-25 | WGS | Schadt Eric | CEO, Dir | M - OptEx | $0.00 | -78.8K | 1.10M | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-01-25 | M | A | 78,812 | — | 129,567 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. |
| 2 | Derivative | Restricted Stock Unit | 2022-01-25 | M | D | 78,812 | $0.00 | 1,103,375 | D | — · — to — | 78,812 Class A Common Stock | (F1) Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F2) 6.25% vest in quarterly installments over the four-year period commencing on July 25, 2021 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. |